Bay Area Biotech Company Takes New Approach in COVID-19 Treatment

Video Credit: CBS 5 SF KPIX
Published on August 11, 2020 - Duration: 02:05s

Bay Area Biotech Company Takes New Approach in COVID-19 Treatment

A South San Francisco biotech firm has come up with a way to make a COVID-19 therapy without relying on repeat antibody donors using a new class of drugs called "recombinant hyperimmunes." Ken Bastida reports.

(8-10-20)


You are here

Related videos from verified sources

Reopening Plans Revamped WIth Simplified, Color-Coded Tiers 02:33
Video credit: CBS 5 SF KPIX - Published on August 29, 2020 

Lenexa company increases COVID-19 test production with expansion 01:39
Video credit: 41 Action News - Published on August 28, 2020 

MEDICAL MONDAY: The Race for a Coronavirus Vaccine 14:32
Video credit: CBS 5 SF KPIX - Published on August 24, 2020 

You might like